Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-029439
Filing Date
2022-08-22
Accepted
2022-08-22 16:30:40
Documents
1
Period of Report
2022-08-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3560
  Complete submission text file 0000899243-22-029439.txt   5026
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O LANTHEUS HOLDINGS, INC. 331 NORTH BILLERICA MA 01862
Business Address
Blanchfield Paul (Reporting) CIK: 0001801395 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 221184080